Independent Prediction of Child Psychiatric Symptoms by Maternal Mental Health and Child Polygenic Risk Scores

dc.contributor.authorChen Lawrence M.
dc.contributor.authorPokhvisneva Irina
dc.contributor.authorLahti-Pulkkinen Marius
dc.contributor.authorKvist Tuomas
dc.contributor.authorBaldwin Jessie R.
dc.contributor.authorParent Carine
dc.contributor.authorSilveira Patricia P.
dc.contributor.authorLahti Jari
dc.contributor.authorRäikkönen Katri
dc.contributor.authorGlover Vivette
dc.contributor.authorO’Connor Thomas G.
dc.contributor.authorMeaney Michael J.
dc.contributor.authorO’Donnell Kieran J.
dc.contributor.organizationfi=psykologia|en=Psychology|
dc.contributor.organization-code2603103
dc.converis.publication-id380717013
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/380717013
dc.date.accessioned2025-08-27T22:55:28Z
dc.date.available2025-08-27T22:55:28Z
dc.description.abstract<h3>Objective</h3><p>Prenatal maternal symptoms of depression and anxiety are associated with an increased risk for child socioemotional and behavioral difficulties, supporting the fetal origins of <a href="https://www.sciencedirect.com/topics/psychology/mental-health" title="Learn more about mental health from ScienceDirect's AI-generated Topic Pages">mental health</a> hypothesis. However, to date, studies have not considered specific genomic risk as a possible confound.</p><h3>Method</h3><p>The Avon Longitudinal Study of Parents and Children (ALSPAC) cohort (n = 5,546) was used to test if child polygenic risk score for attention-deficit/hyperactivity disorder (ADHD), schizophrenia, or depression confounds or modifies the impact of prenatal <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/postpartum-depression" title="Learn more about maternal depression from ScienceDirect's AI-generated Topic Pages">maternal depression</a> and anxiety on child internalizing, externalizing, and total emotional/behavioral symptoms from age 4 to 16 years. Longitudinal child and adolescent symptom data were analyzed in the ALSPAC cohort using generalized estimating equations. Replication analyses were done in an independent cohort (Prevention of <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/pre-eclampsia" title="Learn more about Preeclampsia from ScienceDirect's AI-generated Topic Pages">Preeclampsia</a> and <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/intrauterine-growth-retardation" title="Learn more about Intrauterine Growth Restriction from ScienceDirect's AI-generated Topic Pages">Intrauterine Growth Restriction</a> [PREDO] cohort; n = 514) from Finland, which provided complementary measures of maternal mental health and child psychiatric symptoms.</p><h3>Results</h3><p>Maternal depression and anxiety and child polygenic risk scores independently and additively predicted behavioral and emotional symptoms from childhood through mid-adolescence. There was a robust prediction of child and adolescent symptoms from both prenatal maternal depression (generalized estimating equation estimate = 0.093, 95% CI 0.065-0.121, <em>p</em> = 2.66 × 10<sup>−10</sup>) and anxiety (generalized estimating equation estimate = 0.065, 95% CI 0.037-0.093, <em>p</em> = 1.62 × 10<sup>−5</sup>) after adjusting for child genomic risk for <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/mental-disorder" title="Learn more about mental disorders from ScienceDirect's AI-generated Topic Pages">mental disorders</a>. There was a similar independent effect of maternal depression (<em>B</em> = 0.156, 95% CI 0.066-0.246, <em>p</em> = .001) on child symptoms in the PREDO cohort. Genetically informed sensitivity analyses suggest that shared genetic risk only partially explains the reported association between prenatal maternal depression and offspring mental health.</p><h3>Conclusion</h3><p>These findings highlight the genomic contribution to the fetal origins of mental health hypothesis and further evidence that prenatal maternal depression and anxiety are robust in utero risks for child and adolescent psychiatric symptoms.</p>
dc.identifier.eissn1527-5418
dc.identifier.jour-issn0890-8567
dc.identifier.olddbid203049
dc.identifier.oldhandle10024/186076
dc.identifier.urihttps://www.utupub.fi/handle/11111/49051
dc.identifier.urlhttps://doi.org/10.1016/j.jaac.2023.08.018
dc.identifier.urnURN:NBN:fi-fe2025082789977
dc.language.isoen
dc.okm.affiliatedauthorLahti, Jari
dc.okm.discipline515 Psychologyen_GB
dc.okm.discipline515 Psykologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier Inc.
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1016/j.jaac.2023.08.018
dc.relation.ispartofjournalJournal of the American Academy of Child and Adolescent Psychiatry
dc.source.identifierhttps://www.utupub.fi/handle/10024/186076
dc.titleIndependent Prediction of Child Psychiatric Symptoms by Maternal Mental Health and Child Polygenic Risk Scores
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0890856723021858-main.pdf
Size:
610.39 KB
Format:
Adobe Portable Document Format